Location: Home > Pharma China Web Edition
  • search
  • go
  • Feature Articles
  • 5/29/2023National Value-based Pricing Negotiation for Oncology Drugs — Lessons...
  • 5/29/2023April Sees Deals Worth $2.8B in ADCs, CAR-T Therapies and More (Pharma...
  • 5/26/2023China's Souped-up Data Privacy Laws Deter Researchers (Nature)
  • 5/26/2023China's Middle Class – Growth, Policy, and Consumption (China Briefin...
  • 5/22/2023Doctor-influencers Ae Going Viral in China, Provoking Authorities (ROW...
  • 5/19/2023An AstraZeneca Executive Said the Quiet Part about China Out Loud (Qua...
  • 5/19/2023April Fundraising Rebounds with $315M Capital Injection to Hasten Biop...
  • 5/19/2023CStone Breaks Up With Drugs Partner As U.S. Rollout Stalls (Bamboo Wor...
  • 5/16/2023China's Top 10 Homegrown Novel Drugs in 2022, Vaccines and Cancer Drug...
  • 5/15/2023China's $220 Billion Biotech Initiative Is Struggling to Take Off (Blo...
  • 5/12/2023How China's Population Decline Will Impact Doing Business in the Count...
  • 5/11/2023Lilly Migraine Deal Gives AffaMed New Mojo in Changing China: Video In...
  • 5/11/2023Ethical Review of Science and Technology in China: Draft Trial Measure...
  • 5/9/20232023Q1 China Biopharma Ventures, IPOs and Deals (PharmaDJ)
  • 5/5/2023Reshoring and Nearshoring – Is China Still Relevant? (TMD)
  • 5/4/2023Hainan Allows Import of Urgently Needed Drugs and Medical Devices from...
  • 5/4/2023Does Chinese Tech Giant's AI Algorithm Hold the Key to Better mRNA Vac...
  • 5/3/2023New Report: China Cancer Antibodies Market Trends & Clinical Trials In...
  • 5/3/2023Getting Novel Drugs to China Through Special Zones (thepharmaletter)
  • 5/3/2023China Emerges as New APAC Pharma R&D Engine (BioSpectrum Asia/Citeline...
  • 5/1/2023Broad Economic Rebound Inspires Hope for Faster Recovery of Chinese Ph...
  • 4/27/2023Southeast Asia Is Becoming a Hot New Market for China's Innovative Dru...
  • 4/26/2023Why Rising Demand for Healthcare Is Creating Investment Opportunities ...
  • 4/25/2023Despite Strong Year-on-Year Growth in Q1, Licensing Deals Slow in Marc...
  • 4/25/2023Drug Licensing as Evidence of Evolution, Diffusion and Catch-up in Eas...
  • 4/21/2023AstraZeneca Oncology R&D Head On China Biotech Innovation - Looking Ag...
  • 4/20/2023Gene Editing: China's New Regulations Contain Concerning Loopholes, Ex...
  • 4/20/2023The US Is Relying More on China for Pharmaceuticals — and Vice Versa ...
  • 4/20/2023As Competition Heats Up, China PD-(L)1 Inhibitors Seek More Differenti...
  • 4/19/2023How Can Phase I Data from Western Medicine Accelerate Drug Development...
  • Page:6/7 Total number of articles:195: [First][<<] [3] [4] [5] [6] [7] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group